ZX-29
|
|
2254805-62-2
|
2-Phenylethyl isothiocyanate
|
|
2257-09-2
|
STING agonist-12
|
|
2259624-71-8
|
SM-360320
|
|
226907-52-4
|
Cyclothiazide
|
|
2259-96-3
|
Monaschromone
|
|
22611-36-5
|
MARK4 inhibitor 1
|
|
2271081-58-2
|
E64FC26
|
|
2285446-62-8
|
Maralixibat chloride
|
|
228113-66-4
|
BAY 2666605
|
|
2275774-60-0
|
VULM 1457
|
|
228544-65-8
|
Pratensein
|
|
2284-31-3
|
Tuspetinib
|
|
2294874-49-8
|
FLT3-IN-4
|
|
2304799-09-3
|
JQAD1
|
|
2417097-18-6
|
Matairesinoside
|
|
23202-85-9
|
KB-0742 dihydrochloride
|
|
2416874-75-2
|
Evifacotrep
|
|
2413739-88-3
|
EZM0414
|
|
2411748-50-8
|
Bractoppin
|
|
2290527-07-8
|
XL177A
|
|
2417089-74-6
|
Camonsertib
|
|
2417489-10-0
|
Terameprocol
|
|
24150-24-1
|
HPK1-IN-7
|
|
2320462-65-3
|
CA77.1
|
|
2412270-22-3
|
JKE-1674
|
|
2421119-60-8
|
TP0586532
|
|
2427584-96-9
|
IHMT-MST1-58
|
|
2414484-25-4
|
SY-5609
|
|
2417302-07-7
|
IU1-248
|
|
2307472-03-1
|
G140
|
|
2369751-07-3
|
HWL-088
|
|
2378617-96-8
|
IHMT-PI3Kδ-372
|
|
2429889-62-1
|
IL-17 modulator 4
|
|
2446803-65-0
|
ACSS2-IN-2
|
|
2332820-04-7
|
C16-Ceramide
|
|
24696-26-2
|
SARS-CoV-2 Mpro-IN-9
|
|
244285-12-9
|
15-LOX-1 inhibitor 1
|
|
2349374-37-2
|
Lufotrelvir
|
|
2468015-78-1
|
GSK778
|
|
2451862-42-1
|
G6PDi-1
|
|
2457232-14-1
|
BRM/BRG1 ATP Inhibitor-2
|
|
2368900-77-8
|
dCBP-1
|
|
2484739-25-3
|
IL-17A inhibitor 1
|
|
2452464-73-0
|
BAY-3827
|
|
2377576-35-5
|
CU-115
|
|
2471982-20-2
|
GA-017
|
|
2351906-74-4
|
YS-370
|
|
2470908-79-1
|
SCR130
|
|
2377858-38-1
|
Migoprotafib
|
|
2377352-49-1
|
VU6015929
|
|
2442597-56-8
|
RBN-3143
|
|
2360853-16-1
|
Menin-MLL inhibitor 20
|
|
2448173-47-3
|
D-(+)-Cellobiose-
|
|
2479914-04-8
|
Djalonensone
|
|
23452-05-3
|
MAGL-IN-1
|
|
2324160-91-8
|
Enbezotinib
|
|
2359649-81-1
|
AES-135
|
|
2361659-61-0
|
MS31
|
|
2366264-12-0
|
PARP/PI3K-IN-1
|
|
2337386-47-5
|
PD-1/PD-L1-IN-NP19
|
|
2377916-66-8
|
Zanzalintinib
|
|
2367004-54-2
|
2-MPPA
|
|
254737-29-6
|
M2N12
|
|
2376577-06-7
|
NF-κΒ activator 1
|
|
2387524-59-4
|
BSJ-4-116
|
|
2519823-34-6
|
DHODH-IN-16
|
|
2511248-11-4
|
Phenazine-1-carboxylic acid
|
|
2538-68-3
|
JAK2/FLT3-IN-1
|
|
2387765-27-5
|
Bruceine B
|
|
25514-29-8
|
WDR5-IN-1
|
|
2408842-51-1
|
ASK1-IN-2
|
|
2541792-70-3
|
EMAC10101d
|
|
2561476-24-0
|
Polyinosinic-polycytidylic acid
|
|
24939-03-5
|
Apostatin-1
|
|
2559703-06-7
|
Adaphostin
|
|
241127-58-2
|
Wiskostatin
|
|
253449-04-6
|
Evixapodlin
|
|
2374856-75-2
|
ATX inhibitor 5
|
|
2402772-45-4
|
PF-07220060
|
|
2380321-51-5
|
Elenestinib
|
|
2505078-08-8
|
EB-42486
|
|
2390475-81-5
|
Geranylgeraniol
|
|
24034-73-9
|
SU056
|
|
2376580-08-2
|
GMB-475
|
|
2490599-18-1
|
(S)-Sunvozertinib
|
|
2370013-49-1
|
Palmitic acid-
|
|
2411429-33-7
|
Nampt-IN-5
|
|
2380013-17-0
|
Reverse transcriptase-IN-1
|
|
2380001-43-2
|
JR14a
|
|
2411440-41-8
|
Sovilnesib
|
|
2410796-79-9
|
Lirafugratinib
|
|
2549174-42-5
|
Sincalide
|
|
25126-32-3
|
Anhydroerythromycin A
|
|
23893-13-2
|
BSH-IN-1
|
|
2553217-91-5
|
ASK1-IN-1
|
|
2411382-24-4
|
HS271
|
|
2410393-15-4
|
PLN-1474
|
|
2408065-32-5
|
GNF2133
|
|
2561414-56-8
|
Pumecitinib
|
|
2401057-12-1
|